Skip to main content
Frontiers in Medicine logoLink to Frontiers in Medicine
. 2023 Jul 21;10:1236279. doi: 10.3389/fmed.2023.1236279

Corrigendum: Serum CYR61 is associated with airway inflammation and is a potential biomarker for severity in chronic obstructive pulmonary disease

Zhu-Xia Tan 1,2,, Lin Fu 2,, Wen-Jing Wang 2, Ping Zhan 2, Hui Zhao 2, Hua Wang 1,*, De-Xiang Xu 1,*
PMCID: PMC10401586  PMID: 37547608

In the published article, there was an error in affiliation. The affiliations were listed in the incorrect order. They should appear as:

1 Department of Toxicology, Anhui Medical University, Hefei, China

2 Second Affiliated Hospital, Anhui Medical University, Hefei, China

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Medicine are provided here courtesy of Frontiers Media SA

RESOURCES